Клинико- патогенетические особенности диарейного синдрома, ассоциированного с течением COVID-19
https://doi.org/10.31146/1682-8658-ecg-205-9-276-283
Аннотация
В статье систематизированы результаты исследований по ключевым направлениям проблемы диареи, ассоциированной с COVID-19, проанализированы сложившиеся представления о клинических характеристиках, патогенетических механизмах и связах с развитием дисбиотических изменений и воспалительных заболеваний кишечника, используемых в практике и перспективных лечебных стратегиях.
Об авторах
Галина Семеновна Джулай
ФГБОУ ВО Тверской государственный медицинский университет Минздрава России
Россия
Россия
Татьяна Евгеньевна Джулай
ФГБОУ ВО Тверской государственный медицинский университет Минздрава России
Россия
Россия
Список литературы
1. Ivashkin V.T., Sheptulin A. A., Zolnikova O. Yu., Okhlobystin A. V., Poluektova E. A., Trukhmanov A. S. Novel coronavirus infection (COVID-19) and the digestive system.Russian journal of gastroenterology, hepatology, coloproctology. 2020; 30(3); 7-12. (in Russ.) doi: 10.22416/1382-4376-2020-30-3-7. @@Ивашкин В. Т., Шептулин А. А., Зольникова О. Ю., Охлобыстин А. В., Полуэктова Е. А., Трухманов А. С. Новая коронавирусная инфекция (COVID-19) и система органов пищеварения. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020; 30 (3); 7-12. doi: 10.22416/1382-4376-2020-30-3-7.
2. Drapkina O.M., Maev I. V., Bakulin I. G., et al. Temporary guidelines: “Diseases of the digestive system in the context of a pandemic of a new coronavirus infection (COVID-19)”. Version 2. Preventive medicine. 2021; 24(5-2): 4-41. (in Russ.) doi:10.17116/profmed2021240524. @@Драпкина О. М., Маев И. В., Бакулин И. Г. и др. Временные методические рекомендации: «Болезни органов пищеварения в условиях пандемии новой коронавирусной инфекции (COVID-19)». Версия 2. Профилактическая медицина. 2021; 24 (5-2): 4-41. doi: 10.17116/profmed2021240524.
3. Sarsenbaeva A.S., Lazebnik L. B. Diarrhea in COVID-19 in adults. Experimental and clinical gastroenterology. 2020; 6 (178): 42-54. (in Russ.) doi: 10.31146/1682-8658-ecg-178-6-42-54. @@Сарсенбаева А. С., Лазебник Л. Б. Диарея при COVID-19 у взрослых. Экспериментальная и клиническая гастроэнтерология. 2020; 6 (178): 42-54.
4. Shchikota A.M., Pogonchenkova I. V., Turova E. A., Starodubova A. V., Nosova N. V. Diarrhea associated with COVID-19. Nutrition issues. 2021; 90(6): 18-30. (in Russ.) doi: 10.33029/0042-8833-2021-90-6-18-30. @@Щикота А. М., Погонченкова И. В., Турова Е. А., Стародубова А. В., Носова Н. В. Диарея, ассоциированная с COVID-19. Вопросы питания. 2021; 90 (6): 18-30. doi: 10.33029/0042-8833-2021-90-6-18-30.
5. Zuo T., Zhang F., Lui G. C.Y., et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020; 159 (3): 944-955.e8. doi: 10.1053/j.gastro.2020.05.048.
6. Gaber Y. Diarrhoea and the COVID-19 pandemic. Arab J Gastroenterol. 2020; 21 (3): 146-150. doi: 10.1016/j.ajg.2020.06.001.
7. VillapolS.Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020; 226: 57-69. doi: 10.1016/j.trsl.2020.08.004.
8. Babaev F. A., Babaeva D. F. Diagnosis and treatment of abdominal complications of a new coronavirus infection COVİD-19. Upper Volga Medical Journal. 2021; 20(4):3-7. (in Russ.) @@Бабаев Ф. А., Бабаева Д. Ф. Диагностика и лечение абдоминальных осложнений новой коронавирусной инфекции COVİD-19. Верхневолжский медицинский журнал. 2021; 20 (4): 3-7.
9. Guskova O.N., Dominican I. E., Volodko S. N., et al. Statistics of mortality, hospital mortality and thanatological analysis of deaths in patients with a new coronavirus infection (COVID-19) in the Tver region. Upper Volga Medical Journal. 2021; 20(4):8-13. (in Russ.) @@Гуськова О. Н., Доминикан И. Е., Володько С. Н., Бенидзе И. Р., Кузнецов М. А., Евсеев И. В., Скарякина О. Н., Биюсов М. Х. Статистика смертности, госпитальной летальности и танатологический анализ летальных исходов у больных с новой коронавирусной инфекцией (COVID-19) в Тверской области. Верхневолжский медицинский журнал. 2021; 20 (4): 8-13.
10. Kariyawasam J.C., Jayarajah U., Riza R., Abeysuriya V., Seneviratne S. L. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg. 2021; 115 (12): 1362-1388. doi: 10.1093/trstmh/trab042.
11. Marasco G., Lenti M. V., Cremon C., Barbaro M. R., Stanghellini V., Di Sabatino A., Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterol Motil. 2021; 33 (3): e14104.doi: 10.1111/nmo.14104.
12. Zhang W., Du R. H., Li B., et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9 (1): 386-389. doi: 10.1080/22221751.2020.1729071.
13. Suryana K. D., Simadibrata M., Renaldi K. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges. Acta Med Indones. 2021; 53 (1): 96-104. PMID: 33818412.
14. D’Amico F., Baumgart D. C., Danese S., Peyrin-Biroulet L. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol. 2020; 18 (8): 1663-1672. doi: 10.1016/j.cgh.2020.04.001.
15. Lin L., Jiang X., Zhang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69 (6): 997-1001. doi: 10.1136/gutjnl-2020-321013.
16. Jin X., Lian J. S., Hu J. H., Gao J., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69 (6):1002-1009. doi: 10.1136/gutjnl-2020-320926.
17. Aiyegbusi O.L., Hughes S. E., Turner G., Rivera S. C., McMullan C., Chandan J. S., Haroon S., Price G., Davies E. H., Nirantharakumar K., Sapey E., Calvert M. J.; TLC Study Group. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021; 114 (9): 428-442. doi: 10.1177/01410768211032850.
18. Megyeri K., Dernovics Á., Al-Luhaibi Z.I.I., Rosztóczy A.COVID-19-associated diarrhea. World J Gastroenterol. 2021; 27 (23): 3208-3222. doi: 10.3748/wjg.v27.i23.3208.
19. Zeppa S. D., Agostini D., Piccoli G., Stocchi V., Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Front Cell Infect Microbiol. 2020; 10:576551. doi: 10.3389/fcimb.2020.576551.
20. Sanz S. P., Arguedas L. Y., Mostacero T. S., Cabrera C. T., Sebastián D. J. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol. 2020; 43 (8): 464-471. doi: 10.1016/j.gastrohep.2020.06.004.
21. de Oliveira G. L.V., Oliveira C. N.S., Pinzan C. F., de Salis L. V.V., Cardoso C. R.B. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front Immunol. 2021; 12: 635471. doi: 10.3389/fimmu.2021.635471.
22. Jin B., Singh R., Ha S. E., Zogg H., Park P. J., Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol. 2021; 27 (19): 2341-2352. doi: 10.3748/wjg.v27.i19.2341.
23. Sheikh A. A.E., Sheikh A. B., Shah I., Khair A. H., Javed N.,Shekhar R. COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection. Eur J Case Rep Intern Med. 2021; 8 (8): 002771. doi: 10.12890/2021_002771.
24. Aktas B., Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020; 44 (3): 265-272. doi: 10.3906/biy-2005-102.
25. Vodnar D. C., Mitrea L., Teleky B. E., Szabo K., Călinoiu L. F., Nemeş S. A., Martău G. A. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota. Front Cell Infect Microbiol. 2020; 10: 575559. doi: 10.3389/fcimb.2020.575559.
26. Tian Y., Sun K. Y., Meng T.-Q., et al. Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery. Front Nutr. 2021; 8: 638825. doi: 10.3389/fnut.2021.638825.
27. Ud Din A., Mazhar M., Waseem M., et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021; 133: 110947. doi: 10.1016/j.biopha.2020.110947.
28. Liu F., Ye S., Zhu X., He X., et al. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021; 15 (1): 60. doi: 10.1186/s13256-020-02583-7.
29. Kim H.-N., Joo E.-J., Lee C.-W., Ahn K.-S., Kim H.-L., Park D.-I., Park S.-K. Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study. Microorganisms. 2021; 9 (6): 1237. doi: 10.3390/microorganisms9061237.
30. Zuo T., Zhan H., Zhang F., et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology. 2020; 159 (4): 1302-1310.e5. doi: 10.1053/j.gastro.2020.06.048.
31. Howell M. C., Green R., McGill A.R., Dutta R., Mohapatra S., Mohapatra S. S. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer. Cancers (Basel). 2021; 13 (11): 2676. doi: 10.3390/cancers13112676.
32. Balzora S., Issaka R. B., Anyane-Yeboa A., Gray D. M. 2nd, May F. P. Impact of COVID-19 on colorectal cancer disparities and the way forward. Gastrointest Endosc. 2020; 92 (4): 946-950. doi: 10.1016/j.gie.2020.06.042.
33. Maringe C., Spicer J., Morris M., Purushotham A., Nolte E., Sullivan R., Rachet B., Aggarwal A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21 (8): 1023-1034. doi: 10.1016/S1470-2045(20)30388-0.
34. Smith H.G., Jensen K. K., Jørgensen L. N., Krarup P. M. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark. BJS Open. 2021; 5 (6): zrab108. doi: 10.1093/bjsopen/zrab108.
35. Cai C., Zhang X., Liu Y., Shen E., Feng Z., Guo C., Han Y., Ouyang Y., Shen H. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathog. 2021; 13 (1): 70. doi: 10.1186/s13099-021-00466-w.
36. Merchant J., Lindsey I., James D., Symons N., Boyce S., Jones O., George B., Cunningham C. Maintaining Standards in Colorectal Cancer Surgery During the Global Pandemic: A Cohort Study. World J Surg. 2021; 45 (3): 655-661. doi: 10.1007/s00268-020-05928-x.
37. Barsouk A., Saginala K., Aluru J. S., Rawla P., Barsouk A. US Cancer Screening Recommendations: Developments and the Impact of COVID-19. Med Sci (Basel). 2022; 10 (1): 16. doi: 10.3390/medsci10010016.
38. Muñoz-Duyos A., Abarca-Alvarado N., Lagares-Tena L., Sobrerroca L., Costa D., Boada M., Ureña D., Delgado-Rivilla S. Teleconsultation in a coloproctology unit during the COVID-19 pandemic. Preliminary results. Cir Esp (Engl Ed). 2021; 99 (5): 361-367. doi: 10.1016/j.ciresp.2020.06.019.
39. Sebastian S., Walker G. J., Kennedy N. A., et al. PROTECT-ASUC Study Group Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021; 6 (4): 271-281. doi: 10.1016/S2468-1253(21)00016-9.
40. Carvalho A., Alqusairi R., Adams A., Paul M., Kothari N., Peters S., DeBenedet A.T. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. Am J Gastroenterol. 2020; 115 (6): 942-946. doi: 10.14309/ajg.0000000000000667.
41. Stawinski P., Dziadkowiec K. N., Marcus A. COVID-19-Induced Colitis: A Novel Relationship During Troubling Times. Cureus. 2021; 13 (6): e15870. doi: 10.7759/cureus.15870.
42. Aydın M. F.,Taşdemir H. Ulcerative Colitis in a COVID-19 Patient: A Case Report. Тurk J Gastroenterol. 2021; 32 (6): 543-547. doi: 10.5152/tjg.2021.20851.
43. Suda T., Takahashi M., Katayama Y., Tamano M. COVID-19 pandemic and exacerbation of ulcerative colitis. World J Clin Cases. 2021; 9 (36): 11220-11227. doi: 10.12998/wjcc.v9.i36.11220.
44. Anikhindi S. A., Kumar A., Arora A. COVID-19 in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2020; 14 (12): 1187-1193. doi: 10.1080/17474124.2020.1816822.
45. Rubin D. T., Feuerstein J. D., Wang A. Y., Cohen R. D. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020; 159 (1): 350-357. doi: 10.1053/j.gastro.2020.04.012.
46. Tripathi K., Godoy Brewer G., Nguyen M. T., et al. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2021; izab236. doi: 10.1093/ibd/izab236.
47. Settanni C. R., Ianiro G., Ponziani F. R., Bibbò S., Segal J. P., Cammarota G., Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol. 2021; 27 (43): 7433-7445. doi: 10.3748/wjg.v27.i43.7433.
48. Zhou K.L., Dong S., Fu G. B., Cui S. S., Guo S. Tuina (massage) therapy for diarrhea in COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020; 99 (28): e21293. doi: 10.1097/MD.0000000000021293.
49. Fernández-Quintela A., Milton-Laskibar I., Trepiana J., et al. Key Aspects in Nutritional Management of COVID-19 Patients. J Clin Med. 2020; 9 (8): 2589. doi: 10.3390/jcm9082589.
50. Tutelyan V.A., Nikityuk D. B. The global challenge of the 21st century - COVID-19: the answer to nutrition. Nutrition issues. 2021; 90(5):6-14. (in Russ.) doi: 10.33029/0042-8833-2021-90-5-6-14. @@Тутельян В. А., Никитюк Д. Б. Глобальный вызов XXI века - COVID-19: ответ диетологии. Вопросы питания. 2021; 90 (5): 6-14. doi: 10.33029/0042-8833-2021-90-5-6-14.
51. Song Y., Liu P., Shi X. L., et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020; 69 (6): 1143-1144. doi: 10.1136/gutjnl-2020-320891.
52. Riddle M.S., DuPont H.L., Connor B. A. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol. 2016; 111 (5): 602-22. doi: 10.1038/ajg.2016.126.
53. Kow C.S., Hasan S. S. The use of antimotility drugs in COVID-19 associated diarrhea. J Infect. 2021; 82 (2): e19. doi: 10.1016/j.jinf.2020.09.017.
54. Patel K.P., Patel P. A., Vunnam R. R., Hewlett A. T., Jain R., Jing R., Vunnam S. R. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. J Clin Virol. 2020; 128: 104386. doi: 10.1016/j.jcv.2020.104386.
55. Ivashkin V.T., Yushchuk N. D., Maev I. V., et al. Recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of Clostridium difficile-associated disease.Russian journal of gastroenterology, hepatology, coloproctology. 2016; 26(5):56-65. (in Russ.) @@Ивашкин В. Т., Ющук Н. Д., Маев И. В. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению Clostridium difficile-ассоциированной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26 (5): 56-65.
56. Nguyen Q.V., Chong L. C., Hor Y. Y., Lew L. C., Rather I. A., Choi S. B. Role of Probiotics in the Management of COVID-19: A Computational Perspective. Nutrients. 2022; 14 (2): 274. doi: 10.3390/nu14020274.
57. Din A.U., Mazhar M., Waseem M., et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021; 133: 110947. doi: 10.1016/j.biopha.2020.110947.
58. Gu J., Han B., Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020; 158 (6): 1518-1519. doi: 10.1053/j.gastro.2020.02.054.
59. Tian X., Li C., Huang A., Xia S., et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9 (1): 382-385. doi: 10.1080/22221751.2020.1729069.
60. Zang R., Gomez Castro M. F., McCune B.T., et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5 (47): eabc3582. doi: 10.1126/sciimmunol.abc3582.
Рецензия
Для цитирования:
Джулай Г.С., Джулай Т.Е. Клинико- патогенетические особенности диарейного синдрома, ассоциированного с течением COVID-19. Экспериментальная и клиническая гастроэнтерология. 2022;(9):276-283. https://doi.org/10.31146/1682-8658-ecg-205-9-276-283
For citation:
Dzhulay G.S., Dzhulay T.E. Clinical and pathogenic features of COVID-19- associated diarrhea syndrome. Experimental and Clinical Gastroenterology. 2022;(9):276-283. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-205-9-276-283
Просмотров:
299
Послать статью по эл. почте 